Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats

British Journal of Pharmacology

Volumn 128, Issue 1, 1999, Pages 213-219

  Belichard, P ^a   Luccarini, J M ^a   Defrene E ^a   Faye, P ^a   Franck, R M ^a   Duclos, H ^a   Paquet, J L ^a   Pruneau, D ^a  

^a Laboratoire de Pharmacochimie   (France)

Author keywords

Bradykinin B1 receptor; Cyclophosphamide; Cystitis; Quantitative polymerase chain reaction; Rat; Receptor gene; Sequence analysis; Splice variants; Urinary bladder

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; CAPTOPRIL; CYCLOPHOSPHAMIDE; ICATIBANT; INDOMETACIN; KININ; MESSENGER RNA; PROPIONIC ACID DERIVATIVE; THIORPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; CYSTITIS; INFLAMMATION; MALE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACROLEIN; ANIMALS; BRADYKININ; CYCLOOXYGENASE INHIBITORS; CYCLOPHOSPHAMIDE; CYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INDOMETHACIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROTEASE INHIBITORS; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RNA, MESSENGER; URINARY BLADDER; UROTHELIUM;

EID: 0032866562     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702769     Document Type: Article

References (34)

1. Baklanov, M.M., Golikova, L.N. & Malygin, E.G. (1996). Effect on DNA transcription of nucleotide sequences upstream to T7 promoter. Nucleic Acids Res., 24, 3659-3660.
2. 1 receptor gene: evidence for variable issue expression and alternative splicing. The Fifteenth International Conference on Kinins, Nara, Japan.
3. Boxall, S.J., Wheeldon, A. & Birch, P.J. (1995). Characterisation of the bradykinin receptors that mediate contraction of the rat oesophagus in vitro. Br. J. Pharmacol., 114, 225P.
4. 1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Br. J. Pharmacol., 114, 612-617.
5. Cox, P.J. (1979). Cyclophosphamide cystitis identification of acrolein as the causative agent. Biochem. Pharmacol., 28, 2045-2049.
6. 9-bradykinin. Br. J. Pharmacol., 93, 969-977.
7. Dray, A. (1997), Kinins and their receptors in hyperalgesia. Can. J. Physiol. Pharmacol., 75, 704-712.
8. Droller, M.J., Saral, R. & Santos, G. (1982). Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology, 20, 256-258.
9. 2 receptor in uterus, bladder and Madin-Darby canine kidney cells. Immunopharmacology, 36, 127-133.
10. Foad, B.S. & Hess, E.V. (1976). Urinary bladder complications with cyclophosphamide therapy. Arch. Intern. Med., 136, 616-619.
11. Gayen, A.K. & Peffley, D.M. (1995). The length of 5′-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate. Arch. Biochem. Biophys., 322, 475-485.
12. Gray, K.J., Engelmann, U.H., Johnson, E.H. & Fishman, I.J. (1986). Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy. J. Urol., 136, 497-500.
13. Heesen, M., Berman, M.A., Hopken, U.E., Gerard, N.P. & Dorf, M.E. (1997). Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-lalpha is a ligand for both CXC chemokine receptor-4 isoforms. J. Immunol., 158, 3561-3564.
14. Kenakin, T. (1987). Stimulus-response curves and 'spare receptors'. In: Kenakin T (ed). Pharmacologic Analysis of Drug-Receptor Interaction. Raven Press: New York. pp 37-39.
15. Luce, J.K., Simons, J.A., Stillwell, T.J. & Benson, JR R.C. (1988). Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis. Med. Ped. Oncol., 16, 372-374.
16. Maggi, C.A., Santicioli, P., Del Bianco, E., Lecci, A. & Guliani, S. (1993). Evidence for the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats. Naunyn. Schmiedebergs. Arch. Pharmacol., 347, 432-437.
17. 1 receptors: a review. Immunopharmacology, 30, 1-26.
18. Marceau, F., Barabe, J., St-Pierre, S. & Regoli, D. (1980). Kinin receptors in experimental inflammation. Can. J. Physiol. Pharmacol., 58, 536-542.
19. 1 receptors for kinins. Pharmacol. Rev., 50, 357-386.
20. Meini, S., Lecci, A., Cucchi, P., Catalioto, R.M., Criscuoli, M. & Maggi, C.A. (1998). Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists. J. Pharmacol. Exp. Ther., 287, 137-143.
21. 1 receptors. Br. J. Pharmacol., 117, 1619-1624.
22. 1 receptor gene in inflammation. J. Biol. Chem., 273, 2784-2791.
23. Paiva, A.C.M., Paiva, T.B., Pereira, C.C. & Shimuta, S.I. (1989). Selectivity of bradykinin analogues for receptors mediating contraction and relaxation of the rat duodenum. Br. J. Pharmacol., 98, 206-210.
24. Patra, P.B. & Westfall, D.P. (1996). Potentiation by bradykinin and substance P of purinergic neurotransmission in urinary bladder. J. Urol., 156, 532-535.
25. Phillips, F.S., Sternberg, S.S., Cronin, A.P., & Vidal, P.M. (1961). Cyclophosphamide and urinary bladder toxicity. Cancer Res., 21, 1577-1581.
26. 1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br. J. Pharmacol., 111, 1029-1034.
27. Regoli, D. & Barabe, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
28. 1 receptors in the non-inflamed and inflamed rat urinary bladder. Br. J. Pharmacol., 114, 228P.
29. Saban, M.R., Saban, R. & Bjorling, D.E. (1997a). Kinetics of peptide-induced release of inflammatory mediators by the urinary bladder. Br. J. Urol., 80, 742-747.
30. Saban, R., Franz, J. & Bjorling, D.E. (1997b). Spontaneously released substance P and bradykinin from isolated guinea-pig bladder. Br. J. Urol., 79, 516-524.
31. Stillwell, T.J. & Benson Jr. R.C. (1988). Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer, 61, 451-457.
32. Tallarida, R.J. & Murray, R.B. (1981). Manual of Pharmacologic Calculations with Computer Programs. Springer-Verlag: New York.
33. Zimmermann, K. & Mannhalter, J.W. (1996). Technical aspects of quantitative competitive PCR. Biotechniques, 21, 268-272.
34. Zuraw, B.L., Sugimoto, S., Parsons, C.L., Hugli, T., Lotz, M. & Koziol, J. (1994). Activation of urinary kallikrein in patients with interstitial cystitis. J. Urol., 152, 874-878.